SUPPRESSION OF CORPUS-LUTEUM FUNCTION BY THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST NAL-GLU - EFFECT OF THE DOSE AND TIMING OF HUMAN CHORIONIC-GONADOTROPIN ADMINISTRATION

被引:0
|
作者
DUBOURDIEU, S
CHARBONNEL, B
MASSAI, MR
MARRAOUI, J
SPITZ, I
BOUCHARD, P
机构
[1] CTR BIOMED RES,POPULAT COUNCIL,NEW YORK,NY
[2] HOP BICETRE,SERV ENDOCRINOL,F-94270 LE KREMLIN BICETR,FRANCE
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess the effect of gonadotropin-releasing hormone antagonist Nal-Glu administration in the luteal phase and the potential rescue by exogenous human chorionic gonadotropin (hCG) of corpus luteum (CL) after antagonist treatment. Design: We studied the dose of Nal-Glu required for luteolysis and subsequently we coadministered low doses of hCG for 3 consecutive days either simultaneously to Nal-Glu administration (n = 5), or 48 (n = 5), or 72 hours (n = 5) later. Six additional participants received pharmacological doses of hCG 48 hours after the luteolytic dose of Nal-Glu. Setting: Participants were studied in Clinique Endocrinologique, Nantes, and in Service d'Endocrinologie, Ho triple-overdot ital Bice triple-overdot tre, Le Kremlin Bicetre, France. Participants: Twenty-nine normal young women (ages 20 to 35) were studied. Interventions: None. Main Outcome Measure: Measurements of follicle-stimulating hormone, luteinizing hormone (LH), estradiol, Progesterone (P) levels were performed by radioimmunoassay before, during, and after the various treatment regimens. Results: Complete luteolysis occurred in women who received 10 mg of Nal-Glu daily on days 4 and 5 after the LH surge. The coadministration of Nal-Glu and hCG overrode the effect of the antagonist (P = 48.8 +/- 22.5 versus 60.8 +/- 3.1 nmol/L in controls treated with hCG alone [NS]). When hCG treatment was started 48 hours after Nal-Glu, a partial luteolysis occurred (P = 33.8 +/- 10.9 versus 117 +/- 12.9 nmol/L, P < 0.01). When hCG was started 72 hours after Nal-Glu, a complete luteolysis occurred (P = 5.8 +/- 2.05 versus 36.2 +/- 0.6 nmol/L, P < 0.01). Higher doses of hCG (1,500 or 5,000 IU) administered 72 hours after Nal-Glu resulted in a significant rescue of CL function (P = 37.7 +/- 4.8 and P = 43.8 +/- 22.2 versus 74.5 +/- 19.8 and 130.2 +/- 14.3 nmol/L, P < 0.05), respectively. Conclusions: These results confirm the LH dependence of CL function. The suppression of CL LH support for 72 hours induced a compromise of the CL nonreversible by low doses of hCG mimicking early pregnancy but reversible with pharmacological doses.
引用
收藏
页码:440 / 445
页数:6
相关论文
共 50 条
  • [1] DOSE EFFECTS OF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST, NAL-GLU, COMBINED WITH TESTOSTERONE ENANTHATE ON GONADOTROPIN-LEVELS IN NORMAL MEN
    BAGATELL, CJ
    RIVIER, JE
    BREMNER, WJ
    FERTILITY AND STERILITY, 1995, 64 (01) : 139 - 145
  • [2] EFFECT OF CHORIONIC-GONADOTROPIN ON CORPUS-LUTEUM OF MONKEY
    SURVE, AH
    HARRINGTON, FE
    ELTON, RL
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1973, 144 (03): : 963 - 968
  • [3] EFFECT OF HUMAN CHORIONIC-GONADOTROPIN AND GONADOTROPIN-RELEASING HORMONE ON CORPUS-LUTEUM FUNCTION AND ESTROUS-CYCLE DURATION IN DAIRY HEIFERS
    SEGUIN, BE
    OXENDER, WD
    BRITT, JH
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1977, 38 (08) : 1153 - 1156
  • [4] COMPARATIVE-STUDY OF HIGH-DOSE CHORIONIC-GONADOTROPIN ON THE HUMAN AND RAT CORPUS-LUTEUM AND EFFECT OF GONADOTROPIN-RELEASING HORMONE ON HUMAN LUTEAL FUNCTION
    CALDWELL, BV
    ROTCHELL, YE
    PANG, CY
    ANDERSON, GG
    KASE, N
    BEHRMAN, HR
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1980, 136 (04) : 458 - 464
  • [5] THE SYNERGISTIC EFFECTS OF CLOMIPHENE CITRATE AND HUMAN MENOPAUSAL GONADOTROPIN IN THE FOLLICULOGENESIS OF STIMULATED CYCLES AS ASSESSED BY THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST NAL-GLU
    CASSIDENTI, DL
    PAULSON, RJ
    LOBO, RA
    SAUER, MV
    HUMAN REPRODUCTION, 1992, 7 (03) : 344 - 348
  • [6] VARIABLE TOLERANCE OF THE DEVELOPING FOLLICLE AND CORPUS-LUTEUM TO GONADOTROPIN-RELEASING-HORMONE ANTAGONIST-INDUCED GONADOTROPIN WITHDRAWAL IN THE HUMAN
    HALL, JE
    BHATTA, N
    ADAMS, JM
    RIVIER, JE
    VALE, WW
    CROWLEY, WF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (05): : 993 - 1000
  • [7] INDUCTION OF AZOOSPERMIA IN NORMAL MEN WITH COMBINED NAL-GLU GONADOTROPIN-RELEASING-HORMONE ANTAGONIST AND TESTOSTERONE ENANTHATE
    TOM, L
    BHASIN, S
    SALAMEH, W
    STEINER, B
    PETERSON, M
    SOKOL, RZ
    RIVIER, J
    VALE, W
    SWERDLOFF, RS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (02): : 476 - 483
  • [8] EFFECT OF ADMINISTRATION OF A GONADOTROPIN-RELEASING-HORMONE (GNRH) ANTAGONIST (NAL-GLU) DURING THE PERIOVULATORY PERIOD - THE LUTEINIZING-HORMONE SURGE REQUIRES SECRETION OF GNRH
    DUBOURDIEU, S
    CHARBONNEL, B
    DACREMONT, MF
    CARREAU, S
    SPITZ, IM
    BOUCHARD, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02): : 343 - 347
  • [9] EFFECT OF INTRAUTERINE AND INTRAMUSCULAR ADMINISTRATION OF HUMAN CHORIONIC-GONADOTROPIN ON CORPUS-LUTEUM FUNCTION IN CYCLIC RHESUS-MONKEYS
    WEHRENBERG, WB
    DIERSCHKE, DJ
    WOLF, RC
    VERNON, MW
    BIOLOGY OF REPRODUCTION, 1980, 23 (01) : 10 - 14
  • [10] GONADOTROPIN-RELEASING-HORMONE ANTAGONISTS - EFFECTS ON THE OVARIAN FOLLICLE AND CORPUS-LUTEUM
    HALL, JE
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1993, 36 (03): : 744 - 752